Financials
Value Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses —————— — Research & development —————— — Operating income -118.83 K-298.97 K-182.27 K-166.64 K-154.69 K-212.98 K -716.57 K Non-Operating Income, Total 107.14 K1.2 M1.22 M1.24 M1.17 M1.07 M 4.7 M Interest expense, net of interest capitalized —————— — Non-Operating Income, excl. Interest Expenses 107.14 K1.2 M1.22 M1.24 M1.17 M1.07 M 4.7 M Unusual income/expense —————— — Pretax income -11.69 K905.99 K1.04 M1.08 M1.01 M857.7 K 3.99 M Equity in earnings —————— — Taxes —————— — Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations -11.69 K905.99 K1.04 M1.08 M1.01 M857.7 K 3.99 M Discontinued operations —————— — Net income -11.69 K905.99 K1.04 M1.08 M1.01 M857.7 K 3.99 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders -11.69 K905.99 K1.04 M1.08 M1.01 M857.7 K 3.99 M Basic earnings per share (Basic EPS) 0.060.240.240.280.240.2 0.96 Diluted earnings per share (Diluted EPS) -0.021.810.240.280.240.2 0.96 Average basic shares outstanding 10.04 M32.01 M32.04 M32.05 M32.06 M32.08 M — Diluted shares outstanding 500 K500 K32.04 M32.05 M32.06 M32.08 M — EBITDA —————— — EBIT —————— — Cost of revenue —————— — Other cost of goods sold —————— — Depreciation & amortization (cash flow) —————— —